Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Financials, oils drive European stocks higher

Published 06/29/2009, 12:31 PM
Updated 06/29/2009, 12:56 PM
UK100
-
BARC
-
BP
-
CSGN
-
NOVN
-
UBSN
-
PSHG_p
-
BNPP
-
TTEF
-
SAN
-
NOVOb
-
BG
-

* FTSEurofirst 300 index closes up 1.8 pct

* Financials, oils gain

* Volkswagen recovers from earlier falls

By Joanne Frearson

LONDON, June 29 (Reuters) - European shares closed higher on Monday, with financials given a boost by broker upgrades and rising crude prices lifting energy stocks.

The pan-European FTSEurofirst 300 <.FTEU3> index of top shares closed up 1.8 percent at 859.63 points after falling nearly 2 percent last week.

The European benchmark index is up more than 33 percent from its lifetime low of March 9, as investors have become more confident on the prospects of recovery. It is set to finish the second quarter up more than 17 percent.

"So little on the agenda today ... but it is not a discouraging day, we had a down week last week, now we are just bouncing around and I think where we go depends on the next lot of economic data that comes out," said David Buik, partner at BGC Partners.

Banks added the most points to the index. BNP Paribas , Banco Santander and Barclays were 2.9-4.3 percent higher.

Lloyds gained 6.1 percent after Goldman Sachs upgraded its rating to "buy" from "neutral".

Other financials were given a boost by broker upgrades. Admiral Group ticked up 3.2 percent after Credit Suisse raised its rating for the insurer to "outperform" from "neutral" .

Munich Re rose 3.8 percent after UBS upgraded it stance on the reinsurer to "buy" from "neutral" .

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Across Europe, the FTSE 100 <.FTSE> index was up 1.3 percent, Germany's DAX <.GDAXI> was 2.3 percent higher and France's CAC 40 <.FCHI> was up 2 percent.

VOLKSWAGEN RECOVERS FROM EARLIER FALLS

Energy stocks were higher as crude rose 2.8 percent just above $71 a barrel. BG Group , BP , Royal Dutch Shell and Total were up 2-4.1 percent.

Novo Nordisk jumped 6.9 percent, after falling around 5 percent last week, on expectations that sales of its modern insulins will benefit from concerns over the safety of Sanofi-Aventis rival drug Lantus. [ID:nLT465787]

Irish drugmaker Elan retreated 1.7 percent following earlier gains. The Sunday Times newspaper, said Swiss peer Novartis was in talks to buy parts of the group, including its flagship multiple sclerosis products and its Alzheimer's disease pipeline. [ID:nLS355247]

A spokeswoman for Elan said it did not comment on speculation. A spokesman for Novartis declined to comment. Novartis was down 0.5 percent.

Sanofi was up 1.5 percent, after plunging last week on concerns about imminent new research findings on Lantus and cancer.

Volkswagen recovered from earlier falls to gain 0.7 percent. Lower Saxony, Volkswagen's second-largest shareholder, said it is pushing VW and luxury automaker Porsche to break a deadlock in merger talks as the two German carmakers squabble over a deal and denied making any ultimatum which was "detrimental to the cause". [ID:nLT10323]

Earlier, Volkswagen had fallen after news reports over the weekend indicated that the power struggle with Porsche might have escalated with no clear solution in sight.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"There is a lot of uncertainty, and even contradictory reports, surrounding the whole affair, and investors could be exiting because they don't want to be caught off guard," a Frankfurt-based trader said. (Reporting by Joanne Frearson; Editing by Hans Peters)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.